The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Androgen suppression with abiraterone acetate, leuprolide, PARP inhibition, and stereotactic body radiotherapy (ASCLEPIuS) in high-risk and node positive prostate cancer (PCa): Phase I multicenter results.
 
William Jackson
Research Funding - Janssen Scientific Affairs
 
Robert Dess
No Relationships to Disclose
 
Angela Jia
Consulting or Advisory Role - Blue Earth Diagnostics; Myovant Sciences
Travel, Accommodations, Expenses - Myovant Sciences
 
Himanshu Nagar
Employment - Weill Cornell Medical College
Research Funding - AngioDynamics (Inst); Lantheus Medical Imaging (Inst)
 
Neil Desai
Consulting or Advisory Role - Boston Scientific; Novartis; Telix Pharmaceuticals
Speakers' Bureau - Ultimate Medical Academy
Research Funding - Boston Scientific (Inst); Reflexion Medical (Inst); Reflexion Medical (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer
(OPTIONAL) Uncompensated Relationships - Bayer
 
Raquibul Hannan
No Relationships to Disclose
 
Jason Hearn
No Relationships to Disclose
 
Zachery Reichert
Consulting or Advisory Role - AstraZeneca; Janssen Oncology
Research Funding - AstraZeneca (Inst)
Expert Testimony - Huff Bowell Bailey
 
Ariel Marciscano
No Relationships to Disclose
 
Brian Davis
No Relationships to Disclose
 
Raed Zuhour
Consulting or Advisory Role - Medlever, Inc
 
Nicholas Zaorsky
No Relationships to Disclose
 
Jorge Garcia
Honoraria - Aptitude Health; Astellas Pharma; MJH Associates; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Macrogenics; Pfizer; Targeted Oncology
Research Funding - Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Premier, Inc. (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Novartis; Pfizer
Other Relationship - FDA
 
Pedro Barata
Honoraria - UroToday
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Ipson; Merck; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Bayer (Inst); Caris Life Sciences (Inst); Merck; Pfizer/Astellas (Inst)
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Exelixis; Merck (Inst); Pfizer (Inst)
 
Jason Brown
Honoraria - AstraZeneca
Consulting or Advisory Role - EMD Serono; Johnson & Johnson/Janssen; Pfizer
Speakers' Bureau - EMD Serono
Research Funding - Bicycle Therapeutics (Inst); Merck (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst)
 
Prateek Mendiratta
Honoraria - Astellas Pharma; AstraZeneca; Seagen
Consulting or Advisory Role - BioAscent; Seagen
Speakers' Bureau - Astellas Pharma; AstraZeneca; Omniprex; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Seattle Genetics/Astellas
 
Felix Feng
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Arul Chinnaiyan
Stock and Other Ownership Interests - Ascentage Pharma; EdenRoc Sciences; Esanik Therapeutics Inc; Flamingo Therapeutics; GenePath Dx; LynxDx; RAAPTA; Tempus, Inc
Consulting or Advisory Role - Ascentage Pharma; Esanik Therapeutics; Flamingo Therapeutics; LynxDx; Proteovant; RAAPTA; Tempus, Inc
Patents, Royalties, Other Intellectual Property - GenomeDx- intellectual property, patents; LynxDx- Patents; Tempus Inc,-Intellectual Property
Travel, Accommodations, Expenses - RAAPTA
Other Relationship - Tempus
 
Krithika Suresh
No Relationships to Disclose
 
Daniel Spratt
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Novartis; Pfizer
Research Funding - Janssen (Inst)
(OPTIONAL) Uncompensated Relationships - NCCN